Extracorporeal hyperoxygenation therapy (EHT) for CO poisoning: in vitro and in vivo feasibility of a full-scale batch system

Abstract Carbon monoxide (CO) poisoning is one of the most common causes of injury and death from poisoning. The primary objective of therapy is to eliminate CO from the patient as quickly as possible to prevent acute and long-term effects. The ideal treatment is hyperbaric oxygen in a pressure cham...

Full description

Saved in:
Bibliographic Details
Main Authors: Niklas B. Steuer, Hannah Lüken, Peter C. Schlanstein, Matthias F. Menne, Christiane Hoffmann, Cavan Lübke, Thomas Schmitz-Rode, Sebastian Victor Jansen, Ulrich Steinseifer, Rüdger Kopp
Format: Article
Language:English
Published: Nature Portfolio 2025-02-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-024-84878-z
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823862522885701632
author Niklas B. Steuer
Hannah Lüken
Peter C. Schlanstein
Matthias F. Menne
Christiane Hoffmann
Cavan Lübke
Thomas Schmitz-Rode
Sebastian Victor Jansen
Ulrich Steinseifer
Rüdger Kopp
author_facet Niklas B. Steuer
Hannah Lüken
Peter C. Schlanstein
Matthias F. Menne
Christiane Hoffmann
Cavan Lübke
Thomas Schmitz-Rode
Sebastian Victor Jansen
Ulrich Steinseifer
Rüdger Kopp
author_sort Niklas B. Steuer
collection DOAJ
description Abstract Carbon monoxide (CO) poisoning is one of the most common causes of injury and death from poisoning. The primary objective of therapy is to eliminate CO from the patient as quickly as possible to prevent acute and long-term effects. The ideal treatment is hyperbaric oxygen in a pressure chamber. However, pressure chambers are scarce, and therefore, the most common treatment is normobaric oxygen (NBO), which, however, has limited efficacy. Here, we present a full-scale batch system for extracorporeal hyperoxygenation therapy (EHT), which facilitates CO elimination extracorporeally by increasing the dissolved oxygen concentration in the blood. The EHT was characterized in vitro, resulting in a minimum carboxyhemoglobin half-life of 3.26 ± 0.11 min. In large animal trials the EHT reduced the median carboxyhemoglobin half-life by 42% (29.77 min EHT vs. 70.8 min control (NBO)). However, the EHT also induced oscillations in hemodynamic pressures due to changes in the animals’ circulatory volume during operation. After optimization, the EHT could be a promising option for treating CO poisoning.
format Article
id doaj-art-d5ec0871ef0944c9a761c8b89f7d13cd
institution Kabale University
issn 2045-2322
language English
publishDate 2025-02-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-d5ec0871ef0944c9a761c8b89f7d13cd2025-02-09T12:30:58ZengNature PortfolioScientific Reports2045-23222025-02-0115111310.1038/s41598-024-84878-zExtracorporeal hyperoxygenation therapy (EHT) for CO poisoning: in vitro and in vivo feasibility of a full-scale batch systemNiklas B. Steuer0Hannah Lüken1Peter C. Schlanstein2Matthias F. Menne3Christiane Hoffmann4Cavan Lübke5Thomas Schmitz-Rode6Sebastian Victor Jansen7Ulrich Steinseifer8Rüdger Kopp9Department of Cardiovascular Engineering, Institute of Applied Medical Engineering, Helmholtz Institute, Medical Faculty, RWTH Aachen UniversityDepartment of Intensive Care Medicine, Medical Faculty, RWTH Aachen UniversityDepartment of Cardiovascular Engineering, Institute of Applied Medical Engineering, Helmholtz Institute, Medical Faculty, RWTH Aachen UniversityDepartment of Cardiovascular Engineering, Institute of Applied Medical Engineering, Helmholtz Institute, Medical Faculty, RWTH Aachen UniversityDepartment of Cardiovascular Engineering, Institute of Applied Medical Engineering, Helmholtz Institute, Medical Faculty, RWTH Aachen UniversityDepartment of Intensive Care Medicine, Medical Faculty, RWTH Aachen UniversityInstitute of Applied Medical Engineering, Helmholtz Institute, Medical Faculty, RWTH Aachen UniversityDepartment of Cardiovascular Engineering, Institute of Applied Medical Engineering, Helmholtz Institute, Medical Faculty, RWTH Aachen UniversityDepartment of Cardiovascular Engineering, Institute of Applied Medical Engineering, Helmholtz Institute, Medical Faculty, RWTH Aachen UniversityDepartment of Intensive Care Medicine, Medical Faculty, RWTH Aachen UniversityAbstract Carbon monoxide (CO) poisoning is one of the most common causes of injury and death from poisoning. The primary objective of therapy is to eliminate CO from the patient as quickly as possible to prevent acute and long-term effects. The ideal treatment is hyperbaric oxygen in a pressure chamber. However, pressure chambers are scarce, and therefore, the most common treatment is normobaric oxygen (NBO), which, however, has limited efficacy. Here, we present a full-scale batch system for extracorporeal hyperoxygenation therapy (EHT), which facilitates CO elimination extracorporeally by increasing the dissolved oxygen concentration in the blood. The EHT was characterized in vitro, resulting in a minimum carboxyhemoglobin half-life of 3.26 ± 0.11 min. In large animal trials the EHT reduced the median carboxyhemoglobin half-life by 42% (29.77 min EHT vs. 70.8 min control (NBO)). However, the EHT also induced oscillations in hemodynamic pressures due to changes in the animals’ circulatory volume during operation. After optimization, the EHT could be a promising option for treating CO poisoning.https://doi.org/10.1038/s41598-024-84878-z
spellingShingle Niklas B. Steuer
Hannah Lüken
Peter C. Schlanstein
Matthias F. Menne
Christiane Hoffmann
Cavan Lübke
Thomas Schmitz-Rode
Sebastian Victor Jansen
Ulrich Steinseifer
Rüdger Kopp
Extracorporeal hyperoxygenation therapy (EHT) for CO poisoning: in vitro and in vivo feasibility of a full-scale batch system
Scientific Reports
title Extracorporeal hyperoxygenation therapy (EHT) for CO poisoning: in vitro and in vivo feasibility of a full-scale batch system
title_full Extracorporeal hyperoxygenation therapy (EHT) for CO poisoning: in vitro and in vivo feasibility of a full-scale batch system
title_fullStr Extracorporeal hyperoxygenation therapy (EHT) for CO poisoning: in vitro and in vivo feasibility of a full-scale batch system
title_full_unstemmed Extracorporeal hyperoxygenation therapy (EHT) for CO poisoning: in vitro and in vivo feasibility of a full-scale batch system
title_short Extracorporeal hyperoxygenation therapy (EHT) for CO poisoning: in vitro and in vivo feasibility of a full-scale batch system
title_sort extracorporeal hyperoxygenation therapy eht for co poisoning in vitro and in vivo feasibility of a full scale batch system
url https://doi.org/10.1038/s41598-024-84878-z
work_keys_str_mv AT niklasbsteuer extracorporealhyperoxygenationtherapyehtforcopoisoninginvitroandinvivofeasibilityofafullscalebatchsystem
AT hannahluken extracorporealhyperoxygenationtherapyehtforcopoisoninginvitroandinvivofeasibilityofafullscalebatchsystem
AT petercschlanstein extracorporealhyperoxygenationtherapyehtforcopoisoninginvitroandinvivofeasibilityofafullscalebatchsystem
AT matthiasfmenne extracorporealhyperoxygenationtherapyehtforcopoisoninginvitroandinvivofeasibilityofafullscalebatchsystem
AT christianehoffmann extracorporealhyperoxygenationtherapyehtforcopoisoninginvitroandinvivofeasibilityofafullscalebatchsystem
AT cavanlubke extracorporealhyperoxygenationtherapyehtforcopoisoninginvitroandinvivofeasibilityofafullscalebatchsystem
AT thomasschmitzrode extracorporealhyperoxygenationtherapyehtforcopoisoninginvitroandinvivofeasibilityofafullscalebatchsystem
AT sebastianvictorjansen extracorporealhyperoxygenationtherapyehtforcopoisoninginvitroandinvivofeasibilityofafullscalebatchsystem
AT ulrichsteinseifer extracorporealhyperoxygenationtherapyehtforcopoisoninginvitroandinvivofeasibilityofafullscalebatchsystem
AT rudgerkopp extracorporealhyperoxygenationtherapyehtforcopoisoninginvitroandinvivofeasibilityofafullscalebatchsystem